• Medicus Pharma issued 8,529,412 restricted common shares to officers and employees in lieu of about $1.45 million cash bonuses.
• Shares were priced at $0.17 each, based on the Nasdaq closing price on Sept. 3, 2026.
• No additional consideration was paid to, or received by, the company in the issuance.
• Unregistered sale relied on the Securities Act Section 4(a)(2) private offering exemption.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medicus Pharma Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001062993-26-004898), on September 11, 2026, and is solely responsible for the information contained therein.